Smärtdominerade funktionella mag-tarmsjukdomar hos barn och ...
Smärtdominerade funktionella mag-tarmsjukdomar hos barn och ...
Smärtdominerade funktionella mag-tarmsjukdomar hos barn och ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Regionalt vårdprogram – <strong>Smärtdominerade</strong> <strong>funktionella</strong> <strong>mag</strong>-<strong>tarmsjukdomar</strong> <strong>hos</strong> <strong>barn</strong> <strong>och</strong> ungdomar<br />
C<strong>och</strong>rane Database Syst Rev 2008:CD003017.<br />
74. Kaminski A, Kamper A, Thaler K, et al. Antidepressants for the treatment of<br />
abdominal pain-related functional gastrointestinal disorders in children and<br />
adolescents. C<strong>och</strong>rane Database Syst Rev 2011:CD008013.<br />
75. Teitelbaum JE, Arora R. Long-term efficacy of low-dose tricyclic antidepressants for<br />
children with functional gastrointestinal disorders. Journal of Pediatric<br />
Gastroenterology and Nutrition 2011;53:260–264.<br />
76. Campo JV, Perel J, Lucas A, et al. Citalopram treatment of pediatric recurrent<br />
abdominal pain and comorbid internalizing disorders: an exploratory study. J Am<br />
Acad Child Adolesc Psychiatry 2004;43:1234–1242.<br />
77. Saps M, Youssef N, Miranda A, et al. Multicenter, randomized, placebo-controlled<br />
trial of amitriptyline in children with functional gastrointestinal disorders.<br />
Gastroenterology 2009;137:1261–1269.<br />
78. Bahar RJ, Collins BS, Steinmetz B, et al. Double-blind placebo-controlled trial of<br />
amitriptyline for the treatment of irritable bowel syndrome in adolescents. The<br />
Journal of Pediatrics 2008;152:685–689.<br />
79. Lee-Robichaud H, Thomas K, Morgan J, et al. Lactulose versus Polyethylene Glycol<br />
for Chronic Constipation. C<strong>och</strong>rane Database Syst Rev 2010;7:CD007570.<br />
80. Gordon M, Naidoo K, Akobeng AK, et al. Osmotic and stimulant laxatives for the<br />
management of childhood constipation. C<strong>och</strong>rane Database Syst Rev<br />
2012;7:CD009118.<br />
81. Dupont C, Leluyer B, Maamri N, et al. Double-blind randomized evaluation of<br />
clinical and biological tolerance of polyethylene glycol 4000 versus lactulose in<br />
constipated children. Journal of Pediatric Gastroenterology and Nutrition<br />
2005;41:625–633.<br />
82. Voskuijl W, de Lorijn F, Verwijs W, et al. PEG 3350 (Transipeg) versus lactulose in<br />
the treatment of childhood functional constipation: a double blind, randomised,<br />
controlled, multicentre trial. Gut 2004;53:1590–1594.<br />
83. See MC, Birnbaum AH, Schechter CB, et al. Double-blind, placebo-controlled trial of<br />
famotidine in children with abdominal pain and dyspepsia: global and quantitative<br />
assessment. Dig Dis Sci 2001;46:985–992.<br />
84. Pittler MH, Ernst E. Peppermint oil for irritable bowel syndrome: a critical review<br />
and metaanalysis. Am J Gastroenterol 1998;93:1131–1135.<br />
85. Kline RM, Kline JJ, Di Palma J, et al. Enteric-coated, pH-dependent peppermint oil<br />
capsules for the treatment of irritable bowel syndrome in children. The Journal of<br />
Pediatrics 2001;138:125–128.<br />
Stöd för evidensbaserad medicin, Stockholms läns landsting<br />
- 51 -